SEC Form 10-Q filed by INNOVATE Corp.

Trading To Commence On Split-Adjusted Basis On August 5, 2024 Under Symbol "VATE"

Gainers Freight Technologies (NASDAQ:FRGT) shares increased by 56.8% to $0.98 during Thursday's regular session. The company's market cap stands at $5.0 million. Pixie Dust Technologies (NASDAQ:PXDT) shares increased by 16.86% to $2.01. The market value of their outstanding shares is at $29.8 million. BioNexus Gene Lab (NASDAQ:BGLC) stock increased by 15.04% to $0.58. The company's market cap stands at $10.1 million. Nauticus Robotics (NASDAQ:KITT) stock moved upwards by 12.17% to $0.15. The company's market cap stands at $9.6 million. Exela Technologies (NASDAQ:XELAP) shares rose 11.76% to $1.9. Palladyne AI (NASDAQ:PDYN) stock rose 11.24% to $1.88. The market value of their outstandi

Gainers Archer Aviation (NYSE:ACHR) shares increased by 3.8% to $3.58 during Wednesday's after-market session. The company's market cap stands at $1.1 billion. Velo3D (NYSE:VLD) stock rose 1.47% to $0.14. The company's market cap stands at $42.7 million. Generac Hldgs (NYSE:GNRC) shares moved upwards by 0.93% to $142.36. The company's market cap stands at $8.6 billion. Stanley Black & Decker (NYSE:SWK) shares increased by 0.74% to $85.05. The market value of their outstanding shares is at $13.0 billion. Toro (NYSE:TTC) shares rose 0.59% to $80.11. The market value of their outstanding shares is at $8.3 billion. Ocean Power Techs (AMEX:OPTT) stock increased by 0.55% to $0.18. The compan

- Infrastructure: DBM Global third quarter revenue of $232.8 million -- Life Sciences: R2 reports record worldwide system unit sales growth in the third quarter -- Spectrum: Broadcasting's delivered another quarter of strong growth driven by network launches - NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE) announced today its consolidated results for the third quarter. Financial Summary (in millions, except per share amounts)Three Months Ended September 30, Nine Months Ended September 30,  2024   2023  Increase / (Decrease)  2024   2023  Increase / (Decrease)Revenue$242.2  $375.3  (35.5)% $870.5  $1,062.0  (18.0)%

NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today that it will release its financial results for the third quarter 2024 on Wednesday, November 6, 2024, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and can be accessed by all interested parties through INNOVATE's Investor Relations website at www.innovate-ir.com. To listen to the live call, please go to the "In

- Infrastructure: DBM Global achieved second quarter revenue of $305.2 million -- Life Sciences: R2 achieved record Glacial system sales in North America in the second quarter -- Spectrum: Broadcasting's growth driven by launch of new networks and cost-cutting efforts - NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE) announced today its consolidated results for the second quarter. Financial Summary (in millions, except per share amounts)Three Months Ended June 30, Six Months Ended June 30,  2024  2023  Increase / (Decrease)  2024   2023  Increase / (Decrease)Revenue$313.1 $368.8  (15.1)% $628.3  $686.7  (8.5)%Net income (loss) attribu

10-Q - INNOVATE Corp. (0001006837) (Filer)

8-K - INNOVATE Corp. (0001006837) (Filer)

S-8 - INNOVATE Corp. (0001006837) (Filer)

4 - INNOVATE Corp. (0001006837) (Issuer)

4 - INNOVATE Corp. (0001006837) (Issuer)

4 - INNOVATE Corp. (0001006837) (Issuer)

SC 13D/A - INNOVATE Corp. (0001006837) (Subject)

SC 13D/A - INNOVATE Corp. (0001006837) (Subject)

SC 13D/A - INNOVATE Corp. (0001006837) (Subject)

MediBeacon expands management team as enrollment in Phase 3 study focused on kidney disease is completed ST. LOUIS, May 16, 2023 /PRNewswire/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE:VATE), today announced the appointment of Dr. Steve Miller as chief medical officer. In this role, Dr. Miller will be focused on driving a range of clinical and strategic initiatives. Dr. Miller formerly served as executive vice president and chief clinical officer at Cigna, where he led the company's clinical policy, quality, and per

Catalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced the appointment of Joseph A. Ferraro as Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary. Mr. Ferraro will be responsible for managing Catalent's global legal and compliance operations. He will be based at the company's headquarters in Somerset, New Jersey, head up the company's Legal Leadership Team, and serve on its Executive Leadership Team, reporting directly to Catalent's Executive Vice President and Chief Administrative Officer, Steven Fasman. This press release features multimedia. View the full release here: https:/

NEW YORK, Aug. 02, 2022 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE), today announced the appointment of Amy Wilkinson to fill the remaining vacancy on the INNOVATE Board of Directors. "Amy brings a unique blend of management expertise and global business and policy experience, and we are confident she will help guide us in our mission to drive shareholder value across our Infrastructure, Life Sciences and Spectrum operating segments," said Avie Glazer, Chairman of INNOVATE. "Amy's leadership and strategy consulting experience advising Fortune 500 companies will be a valuable addition to our Board," said Wayne Barr, Jr., Chief Executive Officer of INNOVATE